Psychedelics in Therapy: Dr. Thomas Cabell and Chad Harman's Insights
It certainly seems to have an ability to leverage in a way that we haven't been able to experience in The Last Years.
Imagine a world where psychedelics are part of mainstream therapy for anxiety, depression, and addiction. In this thought-provoking episode of the Positive Sobriety Podcast, hosts Nate Larkin and David Hampton chat with Dr. Thomas Cabell, a Nashville-based cardiologist, and Chad Harman, CEO of Psycheseuticals. They dive into the promising field of psychedelic-assisted treatment and share their firsthand experiences and knowledge about its potential benefits. Dr.
Cabell and Harman discuss the evolving landscape of mental health treatment, emphasizing how psychedelics might revolutionize patient care. From traditional methods to groundbreaking new approaches, they cover it all. You'll hear about their work at Psycheseuticals and the digital media company that connected them. One striking moment in the episode is when Dr. Cabell mentions, 'It certainly seems to have an ability to leverage in a way that we haven't been able to experience in the last years'.
This episode is a treasure trove of information for anyone curious about the future of mental health and addiction treatment. Whether you're a healthcare professional, someone on a recovery journey, or just interested in cutting-edge therapies, this conversation offers a fresh perspective on how psychedelics could change lives.